Here’s whether Merck & Co., Inc. (MRK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.53% over 10 days); strong 1-year return of +55.6%; rising volume confirms the move (1.21x 30d avg). Currently 3.5% off its 52-week high. Score: +6/7.
MRK is in a confirmed uptrend, trading above both its 50-day ($116.18) and 200-day ($103.93) moving averages. An RSI of 66.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +55.6% compares to +24.4% for SPY (beat the market by 31.3%).
$10,000 invested 1 year ago→ $15,562 today
vs. S&P 500 (SPY) — same period beat market by 31.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($103.93)
✓Above 50-day MA ($116.18)
✓RSI(14) neutral zone (30–70) — currently 66.0
✓Positive return (+55.6%)
✓Within 10% of period high (−3.5%)
Period Range $120.79
$76.66$125.14
RSI (14) 66.0
0 · OversoldOverbought · 100
Key Metrics
Price$120.79
Period Return+55.6%
Period High$125.14
Period Low$76.66
Drawdown−3.5%
MA-50$116.18
MA-200$103.93
RSI (14)66.0
Avg Volume (30d)9.5M
vs. SPYbeat by 31.3%
Return Rank#325 of 1245
Trend Signals
Price is above the 200-day moving average ($103.93)
Price is above the 50-day moving average ($116.18)